Patent · US Active

Methods of treating emesis

US8895586B2 · kind B2 · utility

0Cited by
9References
21Claims
0Family size

Inventors

Key dates

Filing dateApr 17, 2013
Grant dateNov 25, 2014
Priority date
Expiry dateApr 17, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/650952
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK1) receptor. The compounds have the general formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.